Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

The cardiovascular and renal protective effects of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1Ras) are enhanced by low/controlled blood pressure (BP). However, the BP-lowering efficacy of SGLT-2is and GLP-1Ras have not been compared direc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuo, Toyoda, Masao, Hatori, Nobuo, Sakai, Hiroyuki, Furuki, Takayuki, Sato, Kazuyoshi, Terauchi, Yasuo, Tamura, Kouichi, Kanamori, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515152/
https://www.ncbi.nlm.nih.gov/pubmed/36167964
http://dx.doi.org/10.1038/s41598-022-20313-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515152/
https://www.ncbi.nlm.nih.gov/pubmed/36167964
http://dx.doi.org/10.1038/s41598-022-20313-5

Ejemplares similares